Clinical Trial Update: Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D [Phase 1, Phase 2]

View source ↗

Summary

Pilot Phase 1/Phase 2 clinical trial investigating ustekinumab for new-onset Type 1 diabetes, sponsored by the University of British Columbia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Stelara (ustekinumab) (ustekinumab)

Snippet

Sponsor: University of British Columbia | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: UNKNOWN